Sowell Joseph A III
Svp; Chief Development Officer
1 company
Insider Signal Score
53
AverageTrades Analyzed
3
12M Win Rate
66.7%
Avg 3M Return
+5.2%
Avg 12M Return
+3.0%
Sowell Joseph A III is a Svp; Chief Development Officer at HCA Healthcare, Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Holdings by Company
HCAAug 5, 2024
Current Shares0
Value-
Net Activity-209,433
Bought: 0Sold: 209.4K
Transaction History
Showing 8 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2022 | HCA Hca Healthcare, Inc. | Svp; Chief Development Officer | Sell | 12,946 | $223.18 | $2,889,303.82 | -100% | +14.2% | +1.0% | |
| Mar 11, 2022 | HCA Hca Healthcare, Inc. | Svp; Chief Development Officer | Sell | 11,522 | $269.00 | $3,099,418.00 | -40.3% | -24.5% | -6.7% | |
| Jan 4, 2022 | HCA Hca Healthcare, Inc. | Svp; Chief Development Officer | Sale+OE | 22,198 | $259.23 | $5,754,389.76 | -64.2% | -5.4% | -3.4% | |
| Feb 4, 2020 | HCA Hca Healthcare, Inc. | Svp; Chief Development Officer | Sell | 21,309 | $145.00 | $3,089,805.00 | -97.1% | - | - | |
| Jan 29, 2020 | HCA Hca Healthcare, Inc. | Svp; Chief Development Officer | Sale+OE | 31,063 | $145.30 | $4,513,488.07 | -98.0% | - | - | |
| Feb 1, 2018 | HCA Hca Healthcare, Inc. | Svp; Chief Development Officer | Sell | 30,195 | $101.02 | $3,050,357.71 | -52.2% | - | - | |
| Jan 30, 2018 | HCA Hca Healthcare, Inc. | Svp; Chief Development Officer | Sale+OE | 22,025 | $101.86 | $2,243,466.50 | -24.0% | - | - | |
| Jan 26, 2018 | HCA Hca Healthcare, Inc. | Svp; Chief Development Officer | Sale+OE | 58,175 | $95.00 | $5,526,625.00 | -91.5% | - | - |